Pedro Lee
Head of Biology CrossPoint Therapeutics
I majored in chemistry at Tufts University, doctorate in biology from UCSD and post-doctoral fellowship at NYU School of Medicine focusing in epigenetics. I was the project leader at Orum Therapeutics for an asset that was eventually licensed-out to a big pharma and that is currently in phase 1 clinical trials.
Seminars
Thursday 11th June 2026
Analyzing Preclinical Data of ADCs With Stealth Body & Their Success in Making ADCs Safer
12:30 pm
- Using Fc-silent technology for ADC development
- Explore how this approach lowers the risk of cytopenias
- Discuss the maintenance of potent anti-cancer efficacy
